Since the Vioxx withdrawal, experts have debated whether other NSAIDs have similar cardiovascular risks
October 2006
Since the Vioxx withdrawal, experts have debated whether other NSAIDs have similar cardiovascular risks.
Now several new studies are shedding more light.
Vioxx (rofecoxib) seems especially risky...even low doses increase heart attack risk. And this risk is seen shortly after starting the drug...not just after 18 months as originally thought.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote